| Serotonin receptors-from molecular biology to clinical applications M Pytliak, V Vargová, V Mechírová, M Felsöci Physiological research 60 (1), 15, 2011 | 439 | 2011 |
| Matrix metalloproteinases V Vargová, M Pytliak, V Mechírová Matrix metalloproteinase inhibitors: specificity of binding and structure …, 2012 | 93 | 2012 |
| Matrix metalloproteinases and their role in oncogenesis: a review M Pytliak, V Vargova, V Mechírová Oncology Research and Treatment 35 (1-2), 49-53, 2012 | 73 | 2012 |
| Adiponectin as a biomarker of clinical manifestation of metabolic syndrome. M Tajtákova, D Petrásova, J Petrovicová, M Pytliak, Z Semanová Endocrine Regulations 40 (1), 15-19, 2006 | 40 | 2006 |
| Drugs and hypoglycemia M Pytliak, V Vargová, V Mechírová Hypoglycemia–causes and occurrences. Shanghai: InTechOpen, 131-48, 2011 | 12 | 2011 |
| Selected hormones levels in individuals with endothelial dysfunction and insulin resistance M Tajtakova, J Petrovicova, P Spurny, M Pytliak, D Petrasova, ... Bratisl Lek Listy 106 (1), 37-40, 2005 | 9 | 2005 |
| Heart Remodelation: Role of MMPs M Pytliak, V Vaník, P Bojčík The role of matrix metalloproteinase in human body pathologies, 37-56, 2017 | 8 | 2017 |
| Maternal autoimmune thyroiditis and congenital malformations of newborns in a cohort of Slovak women. V Vargová, M Pytliak, V Mechírová, M Felšöci Wiener Medizinische Wochenschrift (1946) 160 (17-18), 470-474, 2010 | 4 | 2010 |
| Thyroid gland in the gravidity V Vargová, V Mechírová, M Pytliak Ceska Gynekologie 74 (1), 12-17, 2009 | 3 | 2009 |
| Thyroid disease in the pregnancy and hypotrophy of newborns V Vargová, V Mechírová, M Pytliak, M Tajtáková Ceska Gynekologie 73 (1), 41-46, 2008 | 3 | 2008 |
| Sekundárne dyslipidémie V Vargová, M Pytliak, V Mechírová Vnitřní lékařství 58 (3), 221-227, 2012 | 2 | 2012 |
| Matrix Metalloproteinases. SP Gupta (ed.), Matrix Metalloproteinase Inhibitors V Viola, P Marek, M Viola Experientia Supplementum 103, 2012 | 2 | 2012 |
| Matrix metalloproteinases and their tissue inhibitors in diabetes, atherosclerosis and prediction of the cardiovascular risk V Vargová, M Pytliak, V Mechírová Current Enzyme Inhibition 6 (4), 211-224, 2010 | 2 | 2010 |
| Thyroid disease in the pregnancy and congenital malformations of newborns V Vargová, V Mechírová, M Pytliak, M Tajtáková Ceska Gynekologie 73 (1), 35-40, 2008 | 1 | 2008 |
| Quercetin as a Possible Cardiovascular Agent M Pytliak, V Vaník IntechOpen, 2023 | | 2023 |
| PharmaForum H Perková, I Ferák, P Schöffski, L Cerbone, P Wolter, I De Wever, ... Oncology Research and Treatment 35 (1-2), 56-59, 2012 | | 2012 |
| Contents of Forthcoming Issues· Themenvorschau H Perková, I Ferák, P Schöffski, L Cerbone, P Wolter, I De Wever, ... Oncology Research and Treatment 35 (1-2), 64-64, 2012 | | 2012 |
| PharmaNews/PharmaTicker H Perková, I Ferák, P Schöffski, L Cerbone, P Wolter, I De Wever, ... Oncology Research and Treatment 35 (1-2), 60-60, 2012 | | 2012 |
| Vol. 35, Issue 1-2, February 2012/Band 35, Heft 1-2, Februar 2012 H Perková, I Ferák, P Schöffski, L Cerbone, P Wolter, I De Wever, ... Oncology Research and Treatment 35 (1-2), 2-4, 2012 | | 2012 |
| Mütterliche Autoimmunthyreoiditis und angeborene Missbildungen des Neugeborenen in einer Kohorte von slowakischen Frauen V Vargová, M Pytliak, V Mechírová, M Felšöci Wiener Medizinische Wochenschrift 160, 470-474, 2010 | | 2010 |
